Eleven scientists leading the way in stroke research have been recognized for their exceptional achievements during the American Stroke Association’s International Stroke Conference 2021.
Among those is Dr. Andreas Charidimou, a post-doctoral researcher at Massachusetts General Hospital and Harvard Medical School in Boston.
Charidimou received the the 2021 Mordecai Y.T. Globus New Investigator Award in Stroke.
This award recognizes Globus’ major contributions to research in cerebrovascular disease and his outstanding contributions to the elucidation of the role of neurotransmitters in ischemia and trauma; the interactions among multiple neurotransmitters; mechanisms of hypothermic neuroprotection; and the role of oxygen radical mechanisms and nitric oxide in brain injury.
Charidimou is part of an llustrious group of 2021 award recipients that includes four groundbreaking scientists who have devoted their careers to stroke research, six authors of notable new research and one scientist recognized for outstanding mentorship. To read the full list, click here.
The virtual International Stroke Conference 2021, held from March 17-19, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
Charidimou’s winning presentation “The Boston Criteria V2.0 for Cerebral Amyloid Angiopathy: Updated Criteria and Multicenter MRI-Neuropathology Validation,” is available in an On Demand, pre-recorded session.
For more news at ASA International Stroke Conference 2021, follow us on Twitter @HeartNews and #ISC21.